Why Is LIFESTANCE HEALTH GR (LFST) Stock Up Today?

LifeStance Health (LFST) surged 13.10% to $12.26 on June 30, driven by Hedgeye naming the stock a new long idea with a projected 32, 60% upside. The firm cited strong revenue and EBITDA forecasts, a Q2 earnings beat, and a raised FY2026 sales outlook as key factors. The stock’s intraday performance reflected strong buying pressure, with a high of $12.43 at 11:00 AM ET and a volume of 5.9 million shares, 1.4 times the 3-month average.

What Happened

Hedgeye’s endorsement of LifeStance as a long-term investment triggered a sharp rise in the stock. The firm highlighted the company’s recent financial performance, including a Q2 earnings beat and a raised full-year sales forecast. These developments reinforced investor confidence in the stock’s potential. Additionally, BTIG recently raised its price target to $16 and maintained a Buy rating, further supporting the positive momentum. The company also announced Q3 sales guidance of $420 million to $440 million, exceeding the $418.474 million estimate. These fundamentals contributed to the stock’s strong performance.

What The Data Shows

The stock opened at $10.83 and climbed steadily throughout the session, reaching a high of $12.43 before closing near that level at $12.27. The volume of 5.9 million shares was significantly higher than the 3-month daily average, indicating strong institutional or retail interest. LifeStance has a market cap of $4.1 billion, a P/E ratio of 84.1, and a trailing twelve-month revenue growth of 20.4%. The stock remains within its 52-week range of $3.81 to $11.76, suggesting the move is a sharp but not yet historic reversal. Recent insider transactions show six sales totaling $290.4 million in the last 90 days, with the most recent filing on June 30.

What To Watch

Investors should monitor the company’s Q3 performance against its $420 million to $440 million sales guidance. The stock’s elevated volume and positive coverage suggest continued interest, and any further updates on guidance or earnings could influence its trajectory.

Why is LFST stock up today?

LIFESTANCE HEALTH GR (LFST) is up +9.78% in the latest session. Our newswire has captured 2 stories on LFST across 2 sources in the last 36 hours, with AI sentiment reading bullish (avg 63/100). The most recent driver: "LifeStance rises 13.2%" (The Fly).

Is LFST a buy right now?

Top Tier Newswire does not give financial advice. Our AI sentiment across the last 36 hours of LFST coverage reads 63/100 over 2 stories; treat it as a research signal and do your own diligence.

How fast does this page update?

The data sections refresh continuously as the newswire lands coverage; the written analysis is published once per trading day. Pro subscribers additionally get real-time push alerts, watchlists, and the full live terminal.